Download
Discipline -
Clinical chemistry
Uric acid
Assay format
Optical methods on semi-automated or automated clinical chemistry analysers
Information History
First added in 2019
Changed in 2020
Purpose type
Aid to diagnosis, Monitoring
Purpose
To aid in the diagnosis and to monitor treatment of gout. To aid in the diagnosis of tumour lysis syndrome associated with acute kidney injury by renal urate deposition during chemotherapy administration.
Specimen types
Serum, Plasma
WHO prequalified or recommended products
N/A
GMDN
53583
Uric acid IVD, kit, spectrophotometry
A collection of reagents and other associated materials intended to be used for the qualitative and/or quantitative detection of uric acid in a clinical specimen, using a spectrophotometry method.
The medical device term(s), code(s) and definition(s) in this section were retrieved from databases external to WHO. As there might be more than one name, definition and “Nomenclature Code” related to the specific medical device, please consult https://gmdnagency.org GMDN ®. © GMDN Agency 2005-2024EMDN
W01010232
URIC ACID
The code(s) and term(s) in this section were observed and retrieved from public databases and have not been validated by health regulatory authorities. Please consult your regulatory agency and EMDN site: https://webgate.ec.europa.eu/dyna2/emdnWHO supporting publications
World Health Organization. (2017). WHO list of priority medical devices for cancer management. World Health Organization. https://iris.who.int/handle/10665/255262
Technical specifications
N/A
Related Medical Devices in MeDevIS
SAGE IVD recommended including this test in the EDL on the basis of the scientific validity of the analyte. It was recognized that the test is a foundational IVD test and is included in clinical guidelines.
N/A
The inclusion of this test was based on WHO guidelines and/or technical documents that include recommendations for the use of this test.
N/A